agency news

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK
Grey Healthcare Group, New York, has been hired to handle creative for Escitalopram, a selective serotonin re-uptake inhibitor to be marketed by Forest Laboratories, New York, to treat depression and related conditions. Escitalopram is an enantiomer of Forest’s drug Celexa. The account will be managed by Janet Donnelly, senior vice president, and Anna Maria Echeverri, account supervisor, specialists in the antidepressant category.
BBDO, New York, has resigned the estimated $10-15 million account of Austin, Texas-based Netpliance, which awarded the assignment in February without a review.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in